Fundraising Fox

Evolve Biosystems

Davis, US · Founded 2011 · Delaware corporation · 16 employees on LinkedIn · 2 known investors

Evolve Biosystems develops probiotic strains of B. infantis, including EVC001 and a next-generation drug strain INF108, aimed at supporting the infant gut microbiome and preventing necrotizing enterocolitis (NEC) in premature infants. The company works at the intersection of breast milk research and infant health in the biotech and digital/medical therapeutics space.

Founders & leadership

Evolve Biosystems was founded in 2011 by J. Bruce German, David Mills, and David J. Kyle.

JB
J. Bruce GermanCo-founder
DM
David MillsCo-founder
DJ
David J. KyleCo-founder
JC
John CampbellExecutive
JC
James CampbellExecutive

Board

DJ
Daniel JanneyBoard director
SB
Simon BarnesBoard director
CM
Catherine MackeyBoard director
AL
Anne LoBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$9M disclosed across 1 round · 2015

$9MraisedAug 2015 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel JanneyDirector
  • John CampbellExecutive Officer
  • J. Bruce GermanDirector
  • James CampbellExecutive Officer
  • David MillsExecutive Officer
  • Catherine MackeyDirector
  • David J. KyleExecutive Officer, Director
  • Anne LoDirector
  • Simon BarnesDirector
Offering amount
$9M
Amount sold
$9M
First sale
Jul 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Evolve Biosystems do?
Evolve Biosystems develops probiotic strains of B. infantis, including EVC001 and a next-generation drug strain INF108, aimed at supporting the infant gut microbiome and preventing necrotizing enterocolitis (NEC) in premature infants. The company works at the intersection of breast milk research and infant health in the biotech and digital/medical therapeutics space.
Who founded Evolve Biosystems?
Evolve Biosystems was founded by J. Bruce German, David Mills, David J. Kyle in 2011.
Who are Evolve Biosystems's investors?
Evolve Biosystems's investors include iSelect Fund, Spruce Capital Partners.
How much funding has Evolve Biosystems raised?
Evolve Biosystems has disclosed $9M raised across 1 round.
Where is Evolve Biosystems headquartered?
Evolve Biosystems is headquartered in Davis, US.